article thumbnail

DEA Reaffirms Synthetic THC Compounds Are Schedule I Controlled Substances

The FDA Law Blog

Houck — The Drug Enforcement Administration’s (“DEA’s”) February 13th determination that THC acetate ester (“THCO”) is a schedule I controlled substance under the federal Controlled Substances Act (“CSA”) has received a good amount of attention in the cannabis press. By Larry K. Terrence L. Boos, Ph.D.,

article thumbnail

The 2023 Controlled Substance Assessment Quiz

OctariusRx

The 2023 controlled substance assessment quiz is about to be released! This is our first annual competency assessment focused on controlled substances and regulatory compliance. The quiz focuses on some of the basic elements managing controlled substances. How are you assessing your staff?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What is a Compounding Pharmacy?

BuzzRx

If your doctor’s office has given you a prescription with instructions to fill it at a compounding pharmacy, you might be wondering what exactly this means. Only around 7,500 are compounding pharmacies, of which only 3,000 perform sterile compounding. What does it mean when a pharmacy is compounding?

article thumbnail

The discovery of a new and compounding cybersecurity threat to pharmacies

pharmaphorum

One, someone who should not be able to get their hands on these controlled substances can. Criminals gaining access to controlled substances by simply picking them up at pharmacies is incredibly problematic, especially considering the massive and ongoing opioid crisis.

article thumbnail

Pharmacies Selling PSE: Remember to Train Employees and Self-Certify

The FDA Law Blog

Attorney’s Office for the Western District of Texas announced that People’s Rx, a local chain operating five retail pharmacies and a compounding laboratory in the Austin area, agreed to pay $200,000 to settle allegations that it violated the Controlled Substances Act (“CSA”). 16, 2023 ( DOJ Press Release ).

article thumbnail

Are Disparate Solutions Causing Visibility Gaps in Your Pharmacy Operation?

Omnicell

The operational blind spots caused by disconnected, siloed systems compounded by the delays and errors caused by outdated manual workflows are the hallmarks of operational complexity that impedes ideal perpetual inventory management and leads to financial strains that plague pharmacies.

article thumbnail

HPM Welcomes 15-Year DOJ Veteran, John W.M. Claud, to the Firm

The FDA Law Blog

He also held leading roles in DOJ’s response to multiple significant national health crises, including the COVID-19 pandemic, the 2019 EVALI vaping crisis, and the 2012 New England Compounding Center fungal meningitis outbreak.